Although application of this scoring method was necessary to detect synchronous coregulation of marker expression, it might have lead to failure to demonstrate significant associations of E-cad expression with hormone receptor status and grade of DCIS in the present study. This evidence concerns the gene NR4A1 and ductal breast carcinoma in situ.